Buscar resultados de ensayos clínicos
Metrorrhagia - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: CavatermTM vs TCRE in Women With DUB Condición: Dysfunctional Uterine Bleeding Fecha: 2007-10-24 Intervenciones:
|
Completed |
Nombre del estudio: Endometrial Ablation With Non-hysteroscopic Methods Condición: Dysfunctional Uterine Bleeding Fecha: 2010-08-02 Intervenciones:
|
Completed |
Nombre del estudio: Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment Condición:
Fecha: 2012-07-19 |
Completed |
Nombre del estudio: Continuous Oral Contraceptives (COCs): Are Bleeding Patterns Dependent on the Hormones Given? Condición: Breakthrough Bleeding Fecha: 2005-07-12 Intervenciones: Drug: Birth control pills |
Completed |
Nombre del estudio: A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale Condición: Breakthrough Bleeding Fecha: 2006-10-30 Intervenciones:
|
Completed |
Nombre del estudio: Oral Contraceptives and Subantimicrobial Doxycycline: Effect on Endometrial MMPs Condición: Breakthrough Bleeding Fecha: 2011-11-08 Intervenciones: Drug: Doxycycline 40 mg orally at the start of cycle 3 (study day 57) for 28 days. |
Recruiting |
Nombre del estudio: Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUB Condición: Dysfunctional Uterine Bleeding Fecha: 2014-02-18 Intervenciones:
|
Terminated |
Nombre del estudio: Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist Condición: Dysfunctional Uterine Bleeding Fecha: 2011-06-14 Intervenciones: Drug: Medroxyprogesterone 17-Acetate MPA pills 20 mg (2 X 10 mg) twice daily for 3 weeks |
Completed |
Nombre del estudio: DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding Condición: Dysfunctional Uterine Bleeding Fecha: 2010-06-21 Intervenciones:
|
Recruiting |
Nombre del estudio: Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS) Condición:
|